ISO 10993-17:2023

مواصفة قياسية دولية   الإصدار الحالي
· اعتمدت بتاريخ 13 سبتمبر 2023 ·

Biological evaluation of medical devices — Part 17: Toxicological risk assessment of medical device constituents

التقييم البيولوجي للأجهزة الطبية
* الأحياء الدقيقة الطبية، انظر 07.100.10

ملفات الوثيقة ISO 10993-17:2023

null صفحات
الإصدار الحالي

مجال الوثيقة ISO 10993-17:2023

This document specifies the process and requirements for the toxicological risk assessment of medical device constituents. The methods and criteria used to assess whether exposure to a constituent is without appreciable harm are also specified. The toxicological risk assessment can be part of the biological evaluation of the final product, as described in ISO 10993-1.

The process described in this document applies to chemical characterization information obtained in line with ISO 10993-18. When a toxicological risk assessment of either the compositional information or analytical chemistry data (e.g. extractable data or leachable data) are required to determine whether the toxicological risks related to the constituents are negligible or tolerable.

The process described in this document is not intended to apply to circumstances where the toxicological risk has been estimated by other means, such as:

    constituents, excluding cohort of concern or excluded chemicals, that are present in or extracted from a medical device at an amount representative of patient exposure below a relevant, toxicologically-based reporting threshold (see applicable requirements in ISO 10993-18:2020, Annex E and ISO/TS 21726);

    a new or changed medical device for which chemical or biological equivalence has been established with an existing biocompatible or clinically established medical device (see applicable requirements in ISO 10993-18:2020, Annex C).

The process described in this document is also not applicable to:

    medical device constituents that do not contact the body (e.g. in vitro diagnostics);

    biological risks associated with physical interactions of the medical device with the body (i.e. application of mechanical forces, energy or surface morphology, etc.), provided that the chemical exposure is not changed;

    active pharmaceutical ingredients of device-drug combination products or biologic components of device-biologic combination products as additional regulatory considerations can apply;

    exposure to a particular constituent that arises from sources other than the device, such as food, water or air.

الأكثر مبيعاً

GSO 150-2:2013
 
مواصفة قياسية خليجية
فترات صلاحية المنتجات الغذائية - الجزء الثاني : فترات الصلاحية الاختيارية
OS GSO 150-2:2013
GSO 150-2:2013 
مواصفة قياسية عمانية
فترات صلاحية المنتجات الغذائية - الجزء الثاني : فترات الصلاحية الاختيارية
OS GSO 150-1:2013
GSO 150-1:2013 
مواصفة قياسية عمانية
فترات صلاحية المنتجات الغذائية - الجزء الأول : فترات الصلاحية الإلزامية
GSO 150-1:2013
 
لائحة فنية خليجية
فترات صلاحية المنتجات الغذائية - الجزء الأول : فترات الصلاحية الإلزامية

اعتمدت مؤخراً

ISO 13615:2024
 
مواصفة قياسية دولية
Traditional Chinese medicine — Atractylodes macrocephala rhizome
ISO/IEC/IEEE 8802-15-4:2024
 
مواصفة قياسية دولية
Information technology — Telecommunications and information exchange between systems — Local and metropolitan area networks — Specific requirements — Part 15-4: Wireless medium access control (MAC) and physical layer (PHY) specifications for low-rate wireless personal area networks (WPANs)
ISO/IEC 21122-1:2024
 
مواصفة قياسية دولية
Information technology — JPEG XS low-latency lightweight image coding system — Part 1: Core coding system
ISO/IEC 33202:2024
 
مواصفة قياسية دولية
Software and systems engineering — Core agile practices